Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APRES: Non-operative Management of Acute Uncomplicated Appendicitis in Children
NCT02795793Unknown
- Sponsor
- Sydney Children's Hospitals Network
- Start
- May 2016
- Primary completion
- May 2019
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
Randomised, open-label trial of piperacillin + tazobactam in appendicitis (2 arms), sponsored by Sydney Children's Hospitals Network. Primary endpoint: Unplanned or unnecessary operation(s) and complications at 30 days. Status: unknown.
02
Drugs
piperacillin + tazobactam
03
Conditions
appendicitis
Beyond the preview
Go deeper on NCT02795793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02795793.